Cell Therapy & Immuno-Oncology Expert | Product Marketing Manager @ LUMICKS | PhD in Bioengineering | Wolves FC fan
Huge news in the field of Cell Therapy today with the FDA approval of the first ever engineered T cell receptor (TCR) T cell therapy by Adaptimmune to treat patients suffering with synovial sarcoma solid tumors. Given the diversity of the human TCR repertoire that consists of billions of distinct TCR clonotypes, to find a specific, potent and safe TCR-T cell treatment and scale it up ready for personalized cancer treatments in the clinic is a major scientific milestone Congratulations to everyone involved at Adaptimmune and the patients, caregivers, investigators, and clinical teams 👏 https://lnkd.in/eTScQTfa